Concepedia

Larisa Belyanskaya

LB

16

Publications

1K

Citations

16

H-Index

2001

Active since

Affiliations

Octapharma (Switzerland)(Current)

University Hospital of Zurich

University of Zurich

Russian Children's Clinical Hospital

Octapharma (Austria)

Larisa Belyanskaya is an author at Octapharma (Switzerland) specializing in medicine, cell biology, and tumor biology.

Top concepts

MedicineCell BiologyApoptosisCell DeathImmunologyTumor BiologyTumor MicroenvironmentPathologyCell SignalingCell Physiology

Publications per year

2001–2021

16

Publications

16

The reliability and limits of the MTT reduction assay for carbon nanotubes–cell interaction

Larisa Belyanskaya, Pius Manser, Philipp Spohn et al. · Carbon · 2007 · 190 citations

Engineering, Carbon Nanotubes–cell Interaction, Carbon-based Material +7

Effects of carbon nanotubes on primary neurons and glial cells

Larisa Belyanskaya, Stefan Weigel, Cordula Hirsch et al. · NeuroToxicology · 2009 · 185 citations

Carbon-based Material, Neurophysiology, Carbon Nanotubes +6

Cisplatin activates Akt in small cell lung cancer cells and attenuates apoptosis by survivin upregulation

Larisa Belyanskaya, Sally Hopkins‐Donaldson, Stefanie Kurtz et al. · International Journal of Cancer · 2005 · 102 citations

Exposure on Cell Surface and Extensive Arginine Methylation of Ewing Sarcoma (EWS) Protein

Larisa Belyanskaya, Peter Gehrig, Heinz Gehring · Journal of Biological Chemistry · 2001 · 89 citations · Full text

Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin

Larisa Belyanskaya, Thomas M. Marti, Sally Hopkins-Donaldson et al. · Molecular Cancer · 2007 · 66 citations · Full text

Rows per page

1–5 of 16